CNS pipeline · person
Dawn Svoronos
Chair of the Board of Xenon Pharmaceuticals since June 2024, having served as Lead Independent Director since June 2021 and a director since September 2016. She retired from Merck & Co. in 2011 after a 23-year commercial career, most recently as President of Europe and Canada.
- 1 company
Current roles
- Xenon Pharmaceuticals Inc.Chair of the Board · Board
Appears with
People sharing a company with Dawn.
- Andrea DiFabio · Xenon Pharmaceuticals Inc.
- Christopher Kenney · Xenon Pharmaceuticals Inc.
- Darren Cline · Xenon Pharmaceuticals Inc.
- Elizabeth Garofalo · Xenon Pharmaceuticals Inc.
- Gary Patou · Xenon Pharmaceuticals Inc.
- Gillian Cannon · Xenon Pharmaceuticals Inc.
- Ian Mortimer · Xenon Pharmaceuticals Inc.
- James Empfield · Xenon Pharmaceuticals Inc.
- Justin Gover · Xenon Pharmaceuticals Inc.
- Matthew D. Ronsheim · Xenon Pharmaceuticals Inc.
- Michael Hayden · Xenon Pharmaceuticals Inc.
- Patrick Machado · Xenon Pharmaceuticals Inc.
- Robin Sherrington · Xenon Pharmaceuticals Inc.
- Shelley McCloskey · Xenon Pharmaceuticals Inc.
- Steven Gannon · Xenon Pharmaceuticals Inc.
- Tucker Kelly · Xenon Pharmaceuticals Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.